Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis

Pediatric Pulmonology

Volumn 44, Issue 7, 2009, Pages 706-712

  Cobanoglu, Nazan ^a,b   Atasoy, Halil ^a   Ozcelik, Ugur ^a   Yalcin, Ebru ^a   Dogru, Deniz ^a   Kiper, Nural ^a   Gocmen, Ayhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Mesa Hospital Cankaya   (Turkey)

Author keywords

Bone mineral density; Children; Cystic fibrosis; Cytokine

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BASAL METABOLIC RATE; BLOOD LEVEL; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM INTAKE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENERGY CONSUMPTION; FEMALE; GENOTYPE; HORMONE DETERMINATION; HUMAN; HYDROXYPROLINE URINE LEVEL; LABORATORY TEST; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOLOGY; SCHOOL CHILD; SCORING SYSTEM; URINARY EXCRETION; VITAMIN BLOOD LEVEL;

ALKALINE PHOSPHATASE; BONE DENSITY; CALCIFEDIOL; CALCIUM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; OSTEOCALCIN; PARATHYROID HORMONE;

EID: 67650115737     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21050     Document Type: Article

References (40)

1. Mischler EH, Chesney PJ, Chesney RW, Mazess RB. Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am J Dis Child 1979;133:632-635. (Pubitemid 9212667)
2. Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25-hydroxyvitamin D concentrations and disordered mineral metabolism; in patients with cystic fibrosis. J Pediatr 1979;94:38-42. (Pubitemid 9036125)
3. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005;90:1888-1896.
4. Boyle MP. Update on maintaining bone health in cystic fibrosis. Curr Opin Pulm Med 2006;12:453-458. (Pubitemid 44624607)
5. Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998;19:555-567.
6. Wilson DC, Rashid M, Durie PR, Tsang A, Kalnins D, Andrew M, Corey M, Shin J, Tullis E, Pencharz PB. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat -soluble vitamin combination. J Pediatr 2001;138:851-855. (Pubitemid 32545586)
7. Dif F, Marty C, Baudoin C, de Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone 2004;35:595-603.
8. King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, Wilson JW. Reduced bone density in cystic fibrosis: delta F508 mutation is an independent risk factor. Eur Respir J 2004;25:54-61.
9. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodelling. N Engl J Med 1995;332:305-311.
10. Romas E, Martin TJ. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int 1997;7:S47-S53.
11. Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000;162:789-794.
12. Aris RM, Stephens AR, Ontjes DA, Denene Blackwood A, Lark RK, Hensler MB, Neuringer IP, Lester GE. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000;162:1674-1678. (Pubitemid 30947542)
13. Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples LD, Adams JE. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 2004;59:613-617. (Pubitemid 38901522)
14. Shead EF, Haworth CS, Gunn E, Bilton D, Scott MA, Compston JE. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006;174:306-311. (Pubitemid 44156609)
15. Horowitz M, Xi Y, Wilson K, Kacena MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001;12:9-18. (Pubitemid 32294582)
16. Greally P, Hussain MJ, Vergani D, Price JF. Serum interleukin-1α and soluble interleukin-2 receptor concentrations in cystic fibrosis. Arch Dis Child 1993;68:785-787. (Pubitemid 23199870)
17. Dagli E,Warner JA, Besley CR,Warner JO. Raised serum soluble interleukin-2 concentrations in cystic fibrosis patients with and without evidence of lung disease. Arch Dis Child 1992;67:479-481.
18. Koller DY, Götz M. Clinical relevance of raised soluble interleukin-2 concentrations in cystic fibrosis. Arch Dis Child 1993;68:150. (Pubitemid 23039323)
19. Koller DY, Götz M, Wojnarowski C, Eichler I. Relationship between disease severity and inflammatory markers in cystic fibrosis. Arch Dis Child 1996;75:498-501. (Pubitemid 27008210)
20. Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J, Lewindon P, Wainwright CE. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 2006;61:146-154. (Pubitemid 43235432)
21. Zhang Z, Lai HC. Comparison of the use of body mass index percentiles and percentage of ideal body weight to screen for malnutrition in children with cystic fibrosis. Am J Clin Nutr 2004; 80:982-991. (Pubitemid 41202101)
22. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39:5-41.
23. Angus RM, Sambrook PN, Pocock NA, Eisman JA. A simple method of assessing calcium intake in Caucasian women. J Am Diet Assoc 1989;89:209-214. (Pubitemid 19061840)
24. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
25. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63:24-29. (Pubitemid 9111195)
26. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, Vrielynck S, Heuillon B, Azhar I, Cazenave A, Lawson-Body E, Chedevergne F, Lenoir G. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007;175:951-957. (Pubitemid 46684706)
27. Grey V, Atkinson S, Drury D, Casey L, Ferland G, Gundberg C, Lands LC. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008;122: 1014-1020.
28. Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA, Potter JM, Lewindon PJ, Powell E, Wainwright CE, Bell SC. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis; a controlled cross sectional study. Thorax 2004;59:149-155. (Pubitemid 38223487)
29. Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006;21: 388-396. (Pubitemid 43306560)
30. Schulze KJ, O'Brien KO, Germain-Lee EL, Booth SL, Leonard A, Rosenstein BJ. Calcium kinetics are altered in clinically stable girls with cystic fibrosis. J Clin Endocrinol Metab 2004;89:3385-3391. (Pubitemid 38951908)
31. Schulze KJ, Cutchins C, Rosenstein BJ, Germain-Lee EL, O'Brien KO. Calcium acquisition rates do not support ageappropriate gains in total body bone mineral content in prepuberty and late puberty in girls with cystic fibrosis. Osteoporos Int 2006;17:731-740.
32. Mortensen LA, Chan GM, Alder SC, Marshall BC. Bone mineral status in prepubertal children with cystic fibrosis. J Pediatr 2000; 136:648-652. (Pubitemid 30318396)
33. Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, McL Niven R, Economou G, Horrocks AW, Freemont AJ, Mawer EB, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999;54:961-967. (Pubitemid 29495388)
34. Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, Compston JE, Hodson ME. Vertebral deformities and low bone mineral density in adults with cystic fibrosis; a crosssectional study. Osteoporos Int 2001;12:366-372. (Pubitemid 32606460)
35. Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME,Wang CI. Osteoporosis in cystic fibrosis. J Pediatr 1988;113:295-300.
36. Grey AB, Ames RW, Matthews RD, Reid IR. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993;48:589-593. (Pubitemid 23188429)
37. Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester GE. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 2002;12:151-157. (Pubitemid 34245373)
38. Baroncelli GI, De Luca F, Magazzu G, Arrigo T, Sferlazzas C, Catena C, Bertelloni S, Saggese G. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997;41:397-403. (Pubitemid 27097909)
39. Aris RM, Renner JB,Winders AD, Buell HE, Riggs DB, Lester G E, Ontjes DA. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-193. (Pubitemid 28078199)
40. Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontol Res 2005;40:287-293.